These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21688621)

  • 21. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F; De Luca L; Graham DY
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
    Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
    Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
    Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Should Helicobacter pylori infection be tested and eradicated in patients treated or about to be treated with aspirin or nonsteroidal anti-inflammatory drugs?].
    Thiéfin G
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):415-26. PubMed ID: 12700498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ulcers, Helicobacter pylori infection, platelets and gastrointestinal complications of non-steroidal anti-inflammatory drugs: what are the connections?
    McCarthy DM
    Eur J Surg Suppl; 2002; (587):89-99. PubMed ID: 16144207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: synergy or null effect?
    Am J Manag Care; 2001 Sep; 7(12 Suppl):S402-3. PubMed ID: 11570032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users?
    Sung JJ
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():65-70. PubMed ID: 15335415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Are COX-2 inhibitors truly able to prevent NSAIDs-associated ulcer?].
    Nishida T; Tsujii M; Tsuji S
    Nihon Rinsho; 2004 Mar; 62(3):561-5. PubMed ID: 15038104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori and non-steroidal anti-inflammatory drugs: does infection affect the outcome of NSAID therapy?
    McCarthy DM
    Yale J Biol Med; 1998; 71(2):101-11. PubMed ID: 10378355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of H. pylori infection on upper gastrointestinal damage].
    Kawai T; Fukuzawa M; Moriyasu F; Yamashina A
    Nihon Rinsho; 2010 Nov; 68(11):2020-4. PubMed ID: 21061526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori, gastric ulcer, and agents noxious to the gastric mucosa.
    Laine L
    Gastroenterol Clin North Am; 1993 Mar; 22(1):117-25. PubMed ID: 8449561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Helicobacter pylori infection and NSAIDs on the risk of peptic ulcer bleeding.
    Mahachai V; Thomson AB; Vilaichone RK
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S295-9. PubMed ID: 16083206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [What role today for Helicobacter pylori in peptic ulcer?].
    Cadiot G
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):409-14. PubMed ID: 12700497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-steroidal anti-inflammatory drug gastropathy and Helicobacter pylori infection.
    Taha AS
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S23-6. PubMed ID: 10379466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk and preventive factors of low-dose aspirin-induced gastroduodenal injuries: a comprehensive review.
    Shiotani A; Manabe N; Kamada T; Fujimura Y; Sakakibara T; Haruma K
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():8-12. PubMed ID: 22486865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationship between NSAIDs and H. pylori in peptic ulcer diseases--is the eradication of H. pylori recommended in NSAIDs ulcer?].
    Ota S; Nakajima S; Bamba H
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():565-8. PubMed ID: 16363602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.